These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15997322)

  • 21. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
    Modan M; Harris MI
    Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community screening for diabetes. Low detection rate in a low-risk population.
    Newman WP; Nelson R; Scheer K
    Diabetes Care; 1994 May; 17(5):363-5. PubMed ID: 8062600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening blood donors for diabetes: analysis of use, accuracy, and cost.
    Lenhard MJ; Maser RE; Kolm P; Healy MJ; Seshadri P
    Transfusion; 2013 Nov; 53(11):2776-81. PubMed ID: 23451798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia.
    Rolka DB; Narayan KM; Thompson TJ; Goldman D; Lindenmayer J; Alich K; Bacall D; Benjamin EM; Lamb B; Stuart DO; Engelgau MM
    Diabetes Care; 2001 Nov; 24(11):1899-903. PubMed ID: 11679454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability.
    O'Connor PJ; Rush WA; Cherney LM; Pronk NP
    Eff Clin Pract; 2001; 4(6):271-7. PubMed ID: 11769300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit.
    Sookaneknun P; Saramunee K; Rattarom R; Kongsri S; Senanok R; Pinitkit P; Sawangsri W; Deesin B
    Prim Care Diabetes; 2010 Oct; 4(3):155-64. PubMed ID: 20558122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for diabetes mellitus in general practice using a reflectance meter system. The Islington Diabetes Survey.
    Forrest RD; Jackson CA; Yudkin JS
    Diabetes Res; 1987 Nov; 6(3):119-22. PubMed ID: 3436112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.
    Green FC; Levison R; Newton DJ; Littleford R; Stonebridge PA; Belch JJ
    Int Angiol; 2012 Apr; 31(2):125-8. PubMed ID: 22466976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population.
    Woo YC; Lee CH; Fong CHY; Tso AWK; Cheung BMY; Lam KSL
    PLoS One; 2017; 12(9):e0184840. PubMed ID: 28910380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a public health station for screening of undiagnosed dysglycemia and hypertension.
    Bar-Dayan Y; Boaz M; Landau Z; Zeev F; Jakubowicz D; Wainstein J
    Prim Care Diabetes; 2016 Oct; 10(5):324-8. PubMed ID: 26968251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT.
    Bortheiry AL; Malerbi DA; Franco LJ
    Diabetes Care; 1994 Nov; 17(11):1269-72. PubMed ID: 7821166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could fasting plasma glucose be used for screening high-risk outpatients for gestational diabetes mellitus?
    de Aguiar LG; de Matos HJ; Gomes MB
    Diabetes Care; 2001 May; 24(5):954-5. PubMed ID: 11347763
    [No Abstract]   [Full Text] [Related]  

  • 33. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil.
    Rosa MQM; Rosa RDS; Correia MG; Araujo DV; Bahia LR; Toscano CM
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29419786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discover diabetes: screening for diabetes mellitus in the Waikato.
    Lawrenson RA; Dunn PJ; Jury D; Sceats J
    N Z Med J; 1993 Dec; 106(969):522-4. PubMed ID: 8183493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.